The term COL4A6 Inhibitors refers to a class of chemical compounds that have been designed and developed to specifically target and interfere with the expression or function of the COL4A6 gene. COL4A6, a part of the collagen IV family, encodes for a crucial protein involved in the formation of collagen IV, a major component of basement membranes in various tissues throughout the body. Basement membranes provide structural support and play essential roles in various physiological processes, such as tissue development, integrity, and filtration. Inhibitors within this class are primarily designed to modulate the production or activity of the COL4A6 gene's products, typically by disrupting the gene's transcription, translation, or function at a molecular level.These inhibitors encompass a diverse range of chemical structures and mechanisms of action. Some may act as DNA alkylating agents, forming covalent bonds with DNA strands, which subsequently disrupts the gene's transcription process, leading to reduced mRNA production.
Others may target specific enzymes or proteins involved in the gene expression machinery, impairing the gene's translation into the corresponding COL4A6 protein. Additionally, some inhibitors may impact downstream processes, such as protein assembly or post-translational modifications, thereby reducing the functional activity of the COL4A6 protein in the basement membranes. Researchers have explored a variety of chemical structures and molecular pathways to develop COL4A6 inhibitors, each with the aim of perturbing the expression or function of this gene for investigative or experimental purposes.COL4A6 Inhibitors constitute a chemical class of compounds designed to interfere with the COL4A6 gene, which plays a vital role in the synthesis of collagen IV, a key component of basement membranes. These inhibitors operate through diverse mechanisms, often targeting gene transcription, translation, or protein function, and are valuable tools for elucidating the molecular biology of collagen IV and basement membrane-related processes in scientific research.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Temozolomide | 85622-93-1 | sc-203292 sc-203292A | 25 mg 100 mg | $91.00 $255.00 | 32 | |
Alkylates DNA, disrupting Col4a6 transcription and protein synthesis. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Forms DNA cross-links, interfering with Col4a6 gene expression and translation. | ||||||
Bleomycin | 11056-06-7 | sc-507293 | 5 mg | $275.00 | 5 | |
Induces DNA strand breaks, affecting Col4a6 transcription and translation. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Alkylates DNA and inhibits DNA synthesis, impacting Col4a6 gene expression. | ||||||
2′-Deoxy-2′,2′-difluorocytidine | 95058-81-4 | sc-275523 sc-275523A | 1 g 5 g | $56.00 $128.00 | ||
Inhibits DNA synthesis and repair, affecting Col4a6 mRNA transcription. | ||||||
Topotecan Hydrochloride | 119413-54-6 | sc-204919 sc-204919A | 1 mg 5 mg | $45.00 $102.00 | 2 | |
Inhibits topoisomerase I, altering DNA structure and Col4a6 expression. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Stabilizes microtubules, leading to Col4a6 mRNA degradation. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Interferes with DNA replication and transcription, impacting Col4a6 synthesis. | ||||||
Cyclophosphamide | 50-18-0 | sc-361165 sc-361165A sc-361165B sc-361165C | 50 mg 100 mg 500 mg 1 g | $90.00 $146.00 $469.00 $791.00 | 18 | |
Alkylates DNA and disrupts Col4a6 gene expression. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Inhibits dihydrofolate reductase, impeding Col4a6 mRNA synthesis. | ||||||